대한내분비학회

메뉴 보기

메뉴 닫기


게시판 검색 ~
번호 카테고리 EnM 인용 제목 저자 저널명 출판년도/월
2788 당뇨병/비만/지질 Empagliflozin cardiovascular and renal effectiveness and safety compared to dipeptidyl peptidase-4 inhibitors across 11 countries in Europe and Asia: Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study. Kim Dae Jung Diabetes & metabolism 2023/01
2787 당뇨병/비만/지질 Impact of high myopia on inner retinal layer thickness in type 2 diabetes patients. Jung Tae Kim Scientific reports 2023/01
2786 당뇨병/비만/지질 Effects of Initial Combinations of Gemigliptin Plus Metformin Compared with Glimepiride Plus Metformin on Gut Microbiota and Glucose Regulation in Obese Patients with Type 2 Diabetes: The INTESTINE Study. Soo Lim Nutrients 2023/01
2785 당뇨병/비만/지질 The Effect of Blood Lipids, Type 2 Diabetes, and Body Mass Index on Parkinson's Disease: A Korean Mendelian Randomization Study. Lee Seung Hyun Journal of movement disorders 2023/01
2784 당뇨병/비만/지질 BMI trajectory and inflammatory effects on metabolic syndrome in adolescents. Hae Soon Kim,Hong Young Sun Pediatric research 2023/01
2783 당뇨병/비만/지질 Metabolic Dysfunction-Associated Fatty Liver Disease and Mortality: A Population-Based Cohort Study. Cheol Young Park,Kim Kyung Soo Diabetes & metabolism journal 2023/01
2782 당뇨병/비만/지질 Nonalcoholic fatty liver disease and insulin resistance in children. Ho Seong Kim,Hyun Wook Chae Clinical and experimental pediatrics 2023/01
2781 당뇨병/비만/지질 Advances in Continuous Glucose Monitoring and Integrated Devices for Management of Diabetes with Insulin-Based Therapy: Improvement in Glycemic Control. Kim Jae Hyeon,Yoo Jee Hee Diabetes & metabolism journal 2023/01

TOP

SNS
instagram facebook twitter
PC버전
대한내분비학회

Copyright ⓒ The Korean Endocrine Society. All rights Reserved

[04146] 서울특별시 마포구 마포대로 109 롯데캐슬프레지던트 101동 2503호
  • 사업자 등록번호 : 106-82-31113
  • 대표자 성명 : 정윤석
  • Tel : 02-714-2428 | Fax : 02-714-5103 | E-mail : endo@endocrinology.or.kr